Stockscreener 앱 받기
132.72
0.87%
1.14
시간 외 거래:
132.72
전일 마감가:
$131.58
열려 있는:
$131
하루 거래량:
155.99K
Relative Volume:
1.09
시가총액:
$2.56B
수익:
$152.42M
순이익/손실:
$45.24M
주가수익비율:
52.88
EPS:
2.51
순현금흐름:
$6.97M
1주 성능:
-2.29%
1개월 성능:
+17.91%
6개월 성능:
+13.87%
1년 성능:
+27.25%
1일 변동 폭
$129.55
$133.19
1주일 범위
$129.55
$138.02
52주 변동 폭
$90.29
$143.13
리간드 파마 Stock (LGND) Company Profile
명칭
Ligand Pharmaceuticals Inc
전화
858-550-7500
주소
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
LGND을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
132.72 | 2.54B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
리간드 파마 Stock (LGND) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Stifel | Buy |
| 2024-10-03 | 개시 | Oppenheimer | Outperform |
| 2024-07-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 재개 | Stephens | Overweight |
| 2021-02-04 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-06 | 개시 | Barclays | Overweight |
| 2020-03-24 | 다운그레이드 | Argus | Buy → Hold |
| 2020-03-10 | 개시 | Guggenheim | Neutral |
| 2020-02-06 | 개시 | The Benchmark Company | Buy |
| 2019-09-19 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-06-11 | 개시 | Barclays | Equal Weight |
| 2019-05-03 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-06 | 재확인 | H.C. Wainwright | Buy |
| 2018-10-29 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-11 | 재확인 | Argus | Buy |
| 2018-08-17 | 개시 | Goldman | Neutral |
| 2018-08-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2018-06-21 | 개시 | Argus | Buy |
| 2017-12-27 | 재확인 | H.C. Wainwright | Buy |
| 2017-09-05 | 재개 | H.C. Wainwright | Buy |
| 2016-10-05 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-05 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2016-03-11 | 개시 | Sidoti | Buy |
| 2016-03-03 | 개시 | H.C. Wainwright | Buy |
모두보기
리간드 파마 주식(LGND)의 최신 뉴스
Ligand Pharmaceuticals Incorporated to Host Earnings Call - ACCESS Newswire
Orchestra BioMed secures $70 million from Ligand and Medtronic - Investing.com
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewswire
$70M Strategic Investment Powers Orchestra BioMed's Revolutionary Leadless Pacemaker Technology - Stock Titan
How Ligand Pharmaceuticals Incorporated stock performs during market volatilityTrend Analysis for Safer Trades Gains Popularity - beatles.ru
When is Ligand Pharmaceuticals Incorporated stock expected to show significant growthSmart Portfolio Planner With Proven Results - jammulinksnews.com
Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth - Investing.com Australia
Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth By Investing.com - Investing.com South Africa
Key External Factors That Drive Ligand Pharmaceuticals Incorporated Stock Price MovementsLow Risk Equity Screener With Results Shared - metal.it
What makes Ligand Pharmaceuticals Incorporated stock price move sharplyWeekly Hot Picks With Buy Confidence Released - metal.it
Ligand Pharmaceuticals Incorporated Recovery Likely Here’s What Data ShowsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Published on: 2025-07-29 17:16:20 - metal.it
EQUITY NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand Pharmaceuticals Incorporated and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
Why Ligand Pharmaceuticals Incorporated stock attracts strong analyst attentionDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
Published on: 2025-07-29 03:23:14 - metal.it
What are Ligand Pharmaceuticals Incorporated company’s key revenue driversUnprecedented profits - jammulinksnews.com
RSI Crosses Above 30 for Ligand Pharmaceuticals Incorporated — Reversal in SightAI Based High Gain Watchlist Scanner Shared - beatles.ru
What is the risk reward ratio of investing in Ligand Pharmaceuticals Incorporated stock - jammulinksnews.com
How does Ligand Pharmaceuticals Incorporated compare to its industry peersAchieve breakthrough profits with expert advice - jammulinksnews.com
Is Ligand Pharmaceuticals Incorporated stock overvalued or undervaluedHigh-performance investment picks - jammulinksnews.com
Is Ligand Pharmaceuticals Incorporated stock a growth or value playPrecision Entry Strategy - metal.it
Why is Ligand Pharmaceuticals Incorporated stock attracting strong analyst attentionMarket-beating returns - jammulinksnews.com
Ligand Pharmaceuticals Incorporated Company Revenue and Profit Trends: A Deep Dive10x Potential Stocks - metal.it
New Product Launches: Will They Boost Ligand Pharmaceuticals Incorporated Stock in 2025Daily Stock Radar - metal.it
Ligand Pharmaceuticals Incorporated Stock Analysis and ForecastHigh-margin investment plays - PrintWeekIndia
What analysts say about Ligand Pharmaceuticals Incorporated stockFree Capital Growth Strategies - PrintWeekIndia
What drives Ligand Pharmaceuticals Incorporated stock priceBreakout portfolio performance - Autocar Professional
Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance
Is Ligand Pharmaceuticals Incorporated a good long term investmentHigh-velocity capital appreciation - jammulinksnews.com
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Sarepta Therapeutics (SRPT) - The Globe and Mail
Stifel reiterates Buy rating on Ligand Pharma stock at $143 price target - Investing.com Canada
Teacher Retirement System of Texas Has $534,000 Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD - Investing.com Australia
Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD By Investing.com - Investing.com Nigeria
리간드 파마 (LGND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):